Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 498

1.

Long-term use of a left ventricular assist device for end-stage heart failure.

Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group.

N Engl J Med. 2001 Nov 15;345(20):1435-43.

2.

Left ventricular assist devices as destination therapy: a new look at survival.

Park SJ, Tector A, Piccioni W, Raines E, Gelijns A, Moskowitz A, Rose E, Holman W, Furukawa S, Frazier OH, Dembitsky W.

J Thorac Cardiovasc Surg. 2005 Jan;129(1):9-17. Erratum in: J Thorac Cardiovasc Surg. 2005 Jun;129(6):1464.

3.

Advanced heart failure treated with continuous-flow left ventricular assist device.

Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators.

N Engl J Med. 2009 Dec 3;361(23):2241-51. doi: 10.1056/NEJMoa0909938. Epub 2009 Nov 17.

5.

Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.

McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ.

Circulation. 1994 Nov;90(5 Pt 2):II83-6.

PMID:
7955290
6.

Improving outcomes with long-term "destination" therapy using left ventricular assist devices.

Long JW, Healy AH, Rasmusson BY, Cowley CG, Nelson KE, Kfoury AG, Clayson SE, Reid BB, Moore SA, Blank DU, Renlund DG.

J Thorac Cardiovasc Surg. 2008 Jun;135(6):1353-60; discussion 1360-1. doi: 10.1016/j.jtcvs.2006.09.124.

7.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
8.

Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.

Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, Pierson RN 3rd; INTrEPID Investigators.

J Am Coll Cardiol. 2007 Aug 21;50(8):741-7. Epub 2007 Aug 6.

9.

The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators.

N Engl J Med. 2005 Apr 14;352(15):1539-49. Epub 2005 Mar 7.

10.

Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival.

Cleveland JC Jr, Grover FL, Fullerton DA, Campbell DN, Mitchell MB, Lindenfeld J, Wolfel EE, Lowes BD, Shakar SF, Brieke A, Cannon A, Robertson AD.

J Thorac Cardiovasc Surg. 2008 Sep;136(3):774-7. doi: 10.1016/j.jtcvs.2008.02.087.

11.

HeartMate left ventricular assist device as bridge to heart transplantation.

Koul B, Solem JO, Steen S, Casimir-Ahn H, Granfeldt H, Lönn UJ.

Ann Thorac Surg. 1998 Jun;65(6):1625-30.

PMID:
9647070
12.

Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.

Circulation. 2007 Jul 31;116(5):497-505. Epub 2007 Jul 16.

13.

Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.

John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.

J Thorac Cardiovasc Surg. 2010 Jul;140(1):174-81. doi: 10.1016/j.jtcvs.2010.03.037. Epub 2010 May 5.

14.

Optimal timing of cardiac transplantation after ventricular assist device implantation.

Gammie JS, Edwards LB, Griffith BP, Pierson RN 3rd, Tsao L.

J Thorac Cardiovasc Surg. 2004 Jun;127(6):1789-99.

15.

Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).

Stevenson LW, Miller LW, Desvigne-Nickens P, Ascheim DD, Parides MK, Renlund DG, Oren RM, Krueger SK, Costanzo MR, Wann LS, Levitan RG, Mancini D; REMATCH Investigators.

Circulation. 2004 Aug 24;110(8):975-81. Epub 2004 Aug 16.

16.

Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.

Dembitsky WP, Tector AJ, Park S, Moskowitz AJ, Gelijns AC, Ronan NS, Piccione W Jr, Holman WL, Furukawa S, Weinberg AD, Heatley G, Poirier VL, Damme L, Long JW.

Ann Thorac Surg. 2004 Dec;78(6):2123-9; discussion 2129-30.

PMID:
15561049
17.

Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.

Grady KL, Meyer PM, Dressler D, Mattea A, Chillcott S, Loo A, White-Williams C, Todd B, Ormaza S, Kaan A, Costanzo MR, Piccione W.

Ann Thorac Surg. 2004 Apr;77(4):1321-7.

PMID:
15063260
18.

Use of a continuous-flow device in patients awaiting heart transplantation.

Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, Conte JV, Naka Y, Mancini D, Delgado RM, MacGillivray TE, Farrar DJ, Frazier OH; HeartMate II Clinical Investigators.

N Engl J Med. 2007 Aug 30;357(9):885-96.

19.

Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience.

Vitali E, Lanfranconi M, Bruschi G, Russo C, Colombo T, Ribera E.

J Card Surg. 2003 Mar-Apr;18(2):107-13.

PMID:
12757336
20.

Cardiac replacement with a total artificial heart as a bridge to transplantation.

Copeland JG, Smith RG, Arabia FA, Nolan PE, Sethi GK, Tsau PH, McClellan D, Slepian MJ; CardioWest Total Artificial Heart Investigators.

N Engl J Med. 2004 Aug 26;351(9):859-67.

Supplemental Content

Support Center